2026 SESSION

INTRODUCED

26103422D

HOUSE BILL NO. 831

Offered January 14, 2026

Prefiled January 13, 2026

A BILL to direct the Board of Pharmacy to convene a work group to study medication, drug, and vaccine ingredient labeling.

—————

Patron—Kent

—————

Referred to Committee on Rules

—————

Be it enacted by the General Assembly of Virginia:

1. § 1. That the Board of Pharmacy shall convene a work group of relevant stakeholders to study medication, drug, and vaccine ingredient labeling. In completing its work, the work group shall (i) review all regulations related to medications, drugs, or vaccines sold or distributed in the Commonwealth to ensure that (a) all active and inactive ingredients contained in such medication, drug, or vaccine are clearly listed on the product packaging or accompanying informational insert and (b) accompanying informational inserts are readily available to consumers at a pharmacy upon request and (ii) study and make recommendations on the feasibility of requiring that any medication, drug, or vaccine sold or distributed in the Commonwealth that includes gluten as an active or inactive ingredient include a statement on the packaging or insert that such product contains gluten. The Board shall report the work group's findings and recommendations to the Chairs of the House Committee on Health and Human Services and the Senate Committee on Education and Health by December 1, 2026.